Souza M, Azevedo M S P, Jung K, Cheetham S, Saif L J
Food Animal Health Research Program, Ohio Agricultural Research and Development Center, The Ohio State University, 1680 Madison Avenue, Wooster, OH 44691, USA.
J Virol. 2008 Feb;82(4):1777-86. doi: 10.1128/JVI.01347-07. Epub 2007 Nov 28.
We previously characterized the pathogenesis of two host-specific bovine enteric caliciviruses (BEC), the GIII.2 norovirus (NoV) strain CV186-OH and the phylogenetically unassigned NB strain, in gnotobiotic (Gn) calves. In this study we evaluated the Gn calf as an alternative animal model to study the pathogenesis and host immune responses to the human norovirus (HuNoV) strain GII.4-HS66. The HuNoV HS66 strain caused diarrhea (five/five calves) and intestinal lesions (one/two calves tested) in the proximal small intestine (duodenum and jejunum) of Gn calves, with lesions similar to, but less severe than, those described for the Newbury agent 2 (NA-2) and NB BEC. Viral capsid antigen was also detected in the jejunum of the proximal small intestine of one of two calves tested by immunohistochemistry. All inoculated calves shed virus in feces (five/five calves), and one/five had viremia. Antibodies and cytokine (proinflammatory, tumor necrosis factor alpha [TNF-alpha]; Th1, interleukin-12 [IL-12] and gamma interferon [IFN-gamma]; Th2, IL-4; Th2/T-regulatory, IL-10) profiles were determined in serum, feces, and intestinal contents (IC) of the HuNoV-HS66-inoculated calves (n = 5) and controls (n = 4) by enzyme-linked immunosorbent assay in the acute (postinoculation day 3 [PID 3]) and convalescent (PID 28) stages of infection. The HuNoV-HS66-specific antibody and cytokine-secreting cells (CSCs) were quantitated by ELISPOT in mononuclear cells of local and systemic tissues at PID 28. Sixty-seven percent of the HuNoV-HS66-inoculated calves seroconverted, and 100% coproconverted with immunoglobulin A (IgA) and/or IgG antibodies to HuNoV-HS66, at low titers. The highest numbers of antibody-secreting cells (ASC), both IgA and IgG, were detected locally in intestine, but systemic IgA and IgG ASC responses also occurred in the HuNoV-HS66-inoculated calves. In serum, HuNoV-HS66 induced higher peaks of TNF-alpha and IFN-gamma at PIDs 2, 7, and 10; of IL-4 and IL-10 at PID 4; and of IL-12 at PIDs 7 and 10, compared to controls. In feces, cytokines increased earlier (PID 1) than in serum and TNF-alpha and IL-10 were elevated acutely in the IC of the HS66-inoculated calves. Compared to controls, at PID 28 higher numbers of IFN-gamma and TNF-alpha CSCs were detected in mesenteric lymph nodes (MLN) or spleen and Th2 (IL-4) CSCs were elevated in intestine; IL-10 CSCs were highest in spleen. Our study provides new data confirming HuNoV-HS66 replication and enteropathogenicity in Gn calves and reveals important and comprehensive aspects of the host's local (intestine and MLN) and systemic (spleen and blood) immune responses to HuNoV-HS66.
我们之前已在无菌(Gn)犊牛中对两种宿主特异性牛肠道杯状病毒(BEC)——GIII.2诺如病毒(NoV)CV186 - OH株和系统发育未分类的NB株的发病机制进行了表征。在本研究中,我们评估了Gn犊牛作为一种替代动物模型,用于研究对人诺如病毒(HuNoV)GII.4 - HS66株的发病机制和宿主免疫反应。HuNoV HS66株在Gn犊牛的近端小肠(十二指肠和空肠)中引起腹泻(5/5头犊牛)和肠道病变(2头检测的犊牛中有1头),其病变与纽伯里因子2(NA - 2)和NB BEC所描述的相似,但程度较轻。通过免疫组织化学在2头检测的犊牛之一的近端小肠空肠中也检测到了病毒衣壳抗原。所有接种的犊牛粪便中均排出病毒(5/5头犊牛),5头中有1头出现病毒血症。通过酶联免疫吸附测定法在HuNoV - HS66接种犊牛(n = 5)和对照(n = 4)的血清、粪便和肠内容物(IC)中,在感染的急性期(接种后第3天[PID 3])和恢复期(PID 28)测定抗体和细胞因子(促炎因子、肿瘤坏死因子α [TNF - α];Th1、白细胞介素 - 12 [IL - 12]和γ干扰素[IFN - γ];Th2、IL - 4;Th2/调节性T细胞、IL - 10)谱。在PID 28时,通过ELISPOT对局部和全身组织的单核细胞中的HuNoV - HS66特异性抗体和细胞因子分泌细胞(CSC)进行定量。67%的HuNoV - HS66接种犊牛发生血清转化,100%粪便转化,产生针对HuNoV - HS66的低滴度免疫球蛋白A(IgA)和/或IgG抗体。在肠道局部检测到的分泌抗体细胞(ASC)数量最多,IgA和IgG均如此,但在HuNoV - HS66接种犊牛中也出现了全身性IgA和IgG ASC反应。与对照相比,在血清中,HuNoV - HS66在PID 2、7和10时诱导TNF - α和IFN - γ出现更高峰值;在PID 4时诱导IL - 4和IL - 10出现更高峰值;在PID 7和10时诱导IL - 12出现更高峰值。在粪便中,细胞因子升高的时间比血清中更早(PID 1),并且在HS66接种犊牛的IC中,TNF - α和IL - 10在急性期升高。与对照相比,在PID 28时,在肠系膜淋巴结(MLN)或脾脏中检测到更多的IFN - γ和TNF - α CSC,在肠道中Th2(IL - 4)CSC升高;IL - 10 CSC在脾脏中最高。我们的研究提供了新的数据,证实了HuNoV - HS66在Gn犊牛中的复制和肠道致病性,并揭示了宿主对HuNoV - HS66的局部(肠道和MLN)和全身(脾脏和血液)免疫反应的重要且全面的方面。